Chronic Kidney Disease stage3: Clinical Trials

24 trials for Chronic Kidney Disease stage3, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 6 unknown, 3 recruiting, 2 terminated. 14 Not applicable, 4 Phase 2, 2 Phase 1, 2 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable14Completed 6, Unknown 4, Recruiting 2, Active not recruiting 1, Terminated 1
Phase 24Completed 2, Unknown 2
Phase 12Completed 2
Phase 32Terminated 1, Unknown 1
Phase 42Completed 2

Follow Chronic Kidney Disease stage3: new trials by email Literature Review of Chronic Kidney Disease stage3 trials Research Report on Chronic Kidney Disease stage3

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Feasibility, Safety and Efficacy of a Predominantly Plant-based Diet in an Asian Population With Chronic Kidney Disease
Predominantly Plant-Based CKD Diet, Standard CKD Diet - Chronic Kidney Disease stage3, Chronic Kidney Disease stage4
Not applicableRecruitingChangi General Hospital402026-04-012026-04-22
Effects of Brazil Nut Supplementation in Patients With Chronic Kidney Disease Undergoing Conservative Treatment
Brazil Nut - Chronic Kidney Diseases, Chronic Kidney Disease stage3
Not applicableActive not recruitingUniversidade Federal Fluminense502025-03-302026-05-18
Evaluation of the Safety and Tolerability of Gemini in Subjects With Stage 3-4 Chronic Kidney Disease.
Intravenous Gemini, Intravenous placebo - Renal Insufficiency, Chronic, Chronic Kidney Disease stage3
Phase 1 / Phase 2CompletedRevelation Biosciences, Inc402025-01-202025-10-29
Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease
Low-AGE diet, High-AGE diet - Kidney Failure, Chronic, Chronic Kidney Disease stage3
Not applicableUnknownCentre Hospitalier Saint Joseph Saint Luc de Lyon662024-08-012024-04-04
Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
Empagliflozin 10 MG, Finerenone, Withings BPM Connect - Diabetes Mellitus Type 2 With Proteinuria, Diabetes Mellitus, Type 2
Phase 4CompletedUniversity Medical Center Groningen122024-07-292026-02-13
Evaluation of the Effectiveness of Platelet-based and Microvesicle-based Assays to Predict Thrombotic and Bleeding Risk in Chronic Kidney Disease Patients With Acute Coronary Syndrome
Blood samples - Chronic Kidney Disease stage3
Not applicableRecruitingAssistance Publique Hopitaux De Marseille8502023-10-122023-10-27
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
GLP-1 receptor agonist, SGLT2 inhibitor, Tirzepatide - Chronic Kidney Disease stage3, Chronic Kidney Disease stage4
RecruitingCardenal Herrera University2502023-09-152025-12-30
Validation and Evaluation of a Newly Developed Mobile Diet App
Counseling, Renal Diet App, Printed Nutrition Pamphlet - Chronic Kidney Diseases, Chronic Kidney Disease stage3
Not applicableUnknownUniversiti Putra Malaysia902023-02-152023-01-27
A Pragmatic Approach to CKD Patient Education
CKD "What You Need To Know" Workbook System, CKD Action Plan, CKD Web-based Resource List - Chronic Kidney Disease stage3, Chronic Kidney Disease stage4
Not applicableTerminatedUniversity of Arkansas12023-02-132026-01-07
Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism
CTAP101, Placebo - Chronic Kidney Disease stage3, Chronic Kidney Disease stage4
Phase 3TerminatedOPKO Health, Inc.22023-01-312025-07-25
Study of Sulphoraphane in Chronic Kidney Disease
Sulforaphane - Chronic Kidney Disease stage3, Chronic Kidney Disease stage4
Phase 1CompletedUniversity of Rochester182022-05-022024-08-12
Effect of Intradialytic Exercises in Chronic Kidney Disease Patients
leg pedaling cycling device, sand bags, hemodialysis sessions - Chronic Kidney Disease stage3
Not applicableCompletedCairo University602022-04-302024-03-05
PR-0164 First in Human Clinical Trial of the PAVmed PortIO Intraosseous Infusion System
PAVmed PortIO™ Intraosseous Infusion System - Chronic Kidney Disease stage3, Chronic Kidney Disease stage4
Not applicableCompletedPAVmed Inc.152022-01-202025-06-27
Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management
My Kidney Guru - Chronic Kidney Diseases, Chronic Kidney Disease stage3
Not applicableCompleted3-C Institute for Social Development672021-09-012022-11-30
Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3
Isotonic saline, N-acetyl cysteine, Febuxostat 80 MG - Chronic Kidney Disease stage3, Contrast-induced Nephropathy
Not applicableCompletedAin Shams University1202020-12-012022-03-25
Role of Activated Charcoal in Decreasing Blood Urea, Creatinine and Phosphorous
Activated charcoal, Dry seeds - Chronic Kidney Disease stage3
Phase 2UnknownAssiut University902020-08-012020-05-14
Renal Denervation in Chronic Kidney Disease - RDN-CKD Study
Renal denervation - Uncontrolled Hypertension, Renal Denervation
Not applicableCompletedUniversity of Erlangen-Nürnberg Medical School442020-01-232026-04-30
Pathophysiological Characterization of the Neuromuscular Function of a Population With Multiple Comorbidities Suffering From Chronic Renal Failure in Pre-dialysis.
Discrimination of neuromuscular alterations protocol - Chronic Kidney Failure, Chronic Kidney Disease stage3
WithdrawnCentre Hospitalier le Mans2019-09-012026-07-01
Application of Wearable Devices to Build a Self-Management Model in Chronic Kidney Disease Patients
Mobile health application and social media - Chronic Kidney Disease Stage 1, Chronic Kidney Disease Stage 2
Not applicableCompletedNational Taiwan University Hospital492019-01-132021-08-26
Effect of Empagliflozin on Urinary Excretion of Adenosine and Osteocyte Function in Patients With Chronic Kidney Disease
Empagliflozin 10 MG - Chronic Kidney Disease stage3
Not applicableUnknownMedical University of Lodz452019-01-012021-07-14

Showing 20 of 24. Sign in to see all of them.

Narrower conditions

Renal Insufficiency, Chronic (13)  ·  Diabetes Mellitus, Type 2 (3)  ·  Albuminuria (2)  ·  Diabetes Mellitus (2)  ·  Feeding Behavior (2)  ·  Inflammation (2)  ·  Kidney Failure, Chronic (2)  ·  Renal Insufficiency (2)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Coronary Artery Disease (1)  ·  Diabetes Complications (1)  ·  Diabetic Nephropathies (1)  ·  Fatigue (1)  ·  Hepatitis C (1)  ·  Hyperparathyroidism, Secondary (1)

Broader conditions

Female Urogenital Diseases (15)  ·  Female Urogenital Diseases and Pregnancy Complications (15)  ·  Kidney Diseases (15)  ·  Male Urogenital Diseases (15)  ·  Urogenital Diseases (15)  ·  Urologic Diseases (15)  ·  Chronic Disease (13)  ·  Disease Attributes (13)  ·  Pathologic Processes (13)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Renal Insufficiency (12)  ·  Endocrine System Diseases (5)  ·  Nutritional and Metabolic Diseases (5)  ·  Behavior (4)  ·  Glucose Metabolism Disorders (4)

Interventions

empagliflozin (4)  ·  2S albumin, brazil nut (1)  ·  Acetylcysteine (1)  ·  Angiotensin-Converting Enzyme Inhibitors (1)  ·  Blood Specimen Collection (1)  ·  Canagliflozin (1)  ·  Charcoal (1)  ·  Counseling (1)  ·  Digital Technology (1)  ·  Exenatide (1)  ·  Febuxostat (1)  ·  Liraglutide (1)  ·  Metformin (1)  ·  Renal Dialysis (1)  ·  Sodium Chloride (1)

Sponsors

3-C Institute for Social Development (1)  ·  Ain Shams University (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Assiut University (1)  ·  Cairo University (1)  ·  Cardenal Herrera University (1)  ·  Centre Hospitalier Saint Joseph Saint Luc de Lyon (1)  ·  Centre Hospitalier le Mans (1)  ·  Changi General Hospital (1)  ·  Imam Khomeini Hospital (1)  ·  Kyushu University (1)  ·  Medical University of Lodz (1)  ·  Medical University of Vienna (1)  ·  National Taiwan University Hospital (1)  ·  OPKO Health, Inc. (1)

Countries

United States (6)  ·  France (3)  ·  Egypt (2)  ·  Austria (1)  ·  Brazil (1)  ·  Colombia (1)  ·  Germany (1)  ·  Iran (1)  ·  Japan (1)  ·  Malaysia (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Singapore (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Akhtar Ashfaq, MD (1)  ·  Ana Checa-Ros, MD, PhD (1)  ·  Debra Childress, PHD (1)  ·  Giorgina Piccoli, MD (1)  ·  Gisella Lopez (1)  ·  Hiddo Lambers Heerspink (1)  ·  Iman Sarhan, PhD (1)  ·  Khosro Barkhordari, MD (1)  ·  Lim Jun Hao, Dietitian (1)  ·  Luis D'Marco, MD, PhD (1)  ·  Manfred Hecking, MD (1)

Results publications

PMID 22870215, PMID 25959301, PMID 33320101, PMID 38770818, PMID 40802676, PMID 42530392, PMID 42865317

NIH funding

R01DK128677 (1)